发文分析
近年国家/地区发文量统计
| 国家/地区 | 数量 |
|---|---|
| USA | 113 |
| Italy | 41 |
| England | 34 |
| GERMANY (FED REP GER) | 28 |
| Canada | 24 |
| Australia | 23 |
| Netherlands | 19 |
| Switzerland | 17 |
| New Zealand | 16 |
| CHINA MAINLAND | 13 |
近年机构发文量统计
| 机构 | 数量 |
|---|---|
| UNIVERSITY OF LONDON | 15 |
| SAPIENZA UNIVERSITY ROME | 13 |
| BIOGEN | 9 |
| SPRINGER NATURE | 9 |
| HARVARD UNIVERSITY | 8 |
| UNIVERSITY OF SYDNEY | 8 |
| UNIVERSITY OF TORONTO | 8 |
| PARACELSUS PRIVATE MEDICAL UNIVERSITY | 7 |
| UNIVERSITY OF CALIFORNIA SYSTEM | 7 |
| UNIVERSITY OF MELBOURNE | 7 |
近年文章引用他刊数据
| 文章名称 | 引用次数 |
|---|---|
| A Phase I, Randomized, Double-Blind, Placebo-Controlled,... | 56 |
| Neurotoxicity Associated with CD19-Targeted CAR-T Cell T... | 28 |
| Antidepressant Efficacy and Tolerability of Ketamine and... | 27 |
| Current and Emerging Treatment Strategies for Neuronal C... | 20 |
| Current Approaches and New Developments in the Pharmacol... | 18 |
| Convergent Mechanisms Underlying Rapid Antidepressant Ac... | 18 |
| Pathophysiological Mechanisms in Migraine and the Identi... | 17 |
| Efficacy and Safety of the Newer Multiple Sclerosis Drug... | 16 |
| Pharmacokinetics and Tolerability of Multiple Doses of P... | 14 |
| Cancer Risk in Patients with Multiple Sclerosis: Potenti... | 14 |
近年被他刊引用数据
| 期刊名称 | 引用次数 |
|---|---|
| J AFFECT DISORDERS | 63 |
| CNS DRUGS | 62 |
| EXPERT OPIN PHARMACO | 51 |
| FRONT PSYCHIATRY | 45 |
| SCI REP-UK | 43 |
| NEUROPSYCH DIS TREAT | 42 |
| INT J MOL SCI | 40 |
| PSYCHIAT RES | 37 |
| EUR NEUROPSYCHOPHARM | 35 |
| MULT SCLER RELAT DIS | 35 |